DrugPatentWatch Database Preview
Details for Patent: 8,232,264
» See Plans and Pricing
Which drugs does patent 8,232,264 protect, and when does it expire?
Patent 8,232,264 protects VANOS and is included in one NDA.
This patent has eleven patent family members in nine countries.
Summary for Patent: 8,232,264
| Title: | Compositions and methods for enhancing corticosteroid delivery |
| Abstract: | The present invention comprises a composition, method of enhancing potency and method of delivering corticosteroids in a vehicle comprising at least two penetration enhancers, and solvents and emulsifiers. The propylene glycol and penetration enhancers are present in ratio to the total of the propylene glycol, penetration enhancers, and solvents and emulsifiers of at least about 0.70. |
| Inventor(s): | Gans; Eugene H. (Westport, CT), Wortzman; Mitchell S. (Scottsdale, AZ) |
| Assignee: | Medicis Pharmaceutical Corporation (Scottsdale, AZ) |
| Application Number: | 12/322,346 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 8,232,264 |
|
Patent Claim Types: see list of patent claims | Composition; Compound; |
Drugs Protected by US Patent 8,232,264
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Medicis | VANOS | fluocinonide | CREAM;TOPICAL | 021758-001 | Feb 11, 2005 | AB | RX | Yes | Yes | Start Trial | Start Trial | Y | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,232,264
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2002360589 | Start Trial | |||
| Brazil | 0215254 | Start Trial | |||
| Canada | 2471041 | Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
